Advertisement

Stage Classifications: UICC/AJCC Classifications and the Japanese Classification

  • Hiromasa FujitaEmail author
Chapter
  • 27 Downloads

Abstract

The history, TNM categories, stage grouping, and related categorizations are compared between the UICC/AJCC stage classifications and the Japan Esophageal Society (JES) stage classification which is the official classification of esophageal cancer in Japan. The most commonly used staging system throughout the world is the TNM Classification of Malignant Tumours which is published collaboratively by the UICC and the AJCC. On the other hand, the Japanese Classification of Esophageal Cancer is used throughout Japan and rarely in other countries. There are significant differences between the UICC/AJCC Classifications and the JES Classification in the N categories and in the stage classifications. The N categories are classified by the number of metastasis-positive lymph nodes in the UICC/AJCC Classification, whereas the N categories are classified by the spread of the metastasis-positive lymph nodes in the JES Classification. The UICC/AJCC strongly considers that stage classification should be based on prognostic outcomes, thus they have six-stage classifications—three for squamous cell carcinoma, and three for adenocarcinoma. On the other hand, the JES has only the one stage classification, and this is adopted for prognostic prediction and also plays a role in the guidelines for lymphadenectomy.

Keywords

American Joint Committee on Cancer (AJCC) AJCC Cancer Staging Manual Japan Esophageal Society (JES) Japanese Classification of Esophageal Cancer Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours 

References

  1. 1.
    International Union Against Cancer. TNM classification of malignant tumours. 1st ed. Geneva: International Union Against Cancer; 1968.Google Scholar
  2. 2.
    International Union Against Cancer. TNM classification of malignant tumours. 2nd ed. Geneva: International Union Against Cancer; 1974.Google Scholar
  3. 3.
    International Union Against Cancer. TNM classification of malignant tumours. 3rd ed. Geneva: International Union Against Cancer; 1978.Google Scholar
  4. 4.
    International Union Against Cancer. TNM classification of malignant tumours. 4th ed. Berlin/Heidelberg/New York/London/Paris/Tokyo: Springer; 1987.Google Scholar
  5. 5.
    International Union Against Cancer. TNM classification of malignant tumours. 5th ed. New York/Chichester/Weinheim/Brisbane/Singapore/Toronto: Wiley-Liss; 1997.Google Scholar
  6. 6.
    International Union Against Cancer. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.Google Scholar
  7. 7.
    International Union Against Cancer. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009.Google Scholar
  8. 8.
    International Union Against Cancer. TNM classification of malignant tumours. 8th ed. New York: Wiley-Blackwell; 2017.Google Scholar
  9. 9.
    American Joint Committee for Cancer Staging and End Results Reporting. Manual for staging of cancer. 1st ed. Chicago: American Joint Committee; 1977.Google Scholar
  10. 10.
    Japanese Society of Esophageal Diseases. Esophageal cancer–descriptive rules in clinic and pathology. 1st ed. Tokyo: Japanese Society of Esophageal Diseases; 1969. (in Japanese)Google Scholar
  11. 11.
    American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York/Dordrecht/Heidelberg/London: Springer; 2010.CrossRefGoogle Scholar
  12. 12.
    American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. New York/Dordrecht/Heidelberg/London: Springer; 2017.Google Scholar
  13. 13.
    American Joint Committee on Cancer. Manual for staging of cancer. 2nd ed. Philadelphia/London/Mexico City/New York/St Louis/Sao Paulo/Sydney: Lippincott Company; 1983.Google Scholar
  14. 14.
    American Joint Committee on Cancer. Manual for staging of cancer. 3rd ed. Philadelphia/London/Mexico City/New York/St. Louis/Sao Paulo/Sydney: Lippincott Company; 1988.Google Scholar
  15. 15.
    American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: Lippincott Company; 1992.Google Scholar
  16. 16.
    American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia/New York: Lippincott-Raven; 1997.Google Scholar
  17. 17.
    American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York/Berlin/Heidelberg/Barcelona/Hong Kong/London/Milan/Paris/Singapore/Tokyo: Springer; 2002.Google Scholar
  18. 18.
    Ishwaran H, Blackstone EH, Apperson-Hansen C, Rice TW. A novel approach to cancer staging: application to esophageal cancer. Biostatistics. 2009;10:603–20.CrossRefGoogle Scholar
  19. 19.
    Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Worldwide esophageal cancer collaboration. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer staging manuals. Cancer. 2010;116:3763–73.Google Scholar
  20. 20.
    Rice TW, Patil DT, Blackstone EH. Eighth edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothoracic Surg. 2017;6:119–30.Google Scholar
  21. 21.
    Rice TW, Apperson-Hansen C, Dipaola LM, Semple ME, Lerut TEMR, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BPL, Chen KN, Davies AR, D’Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Driffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH. Worldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus. 2016;29:707–14.Google Scholar
  22. 22.
    Rice TW, Chen LQ, Hifstetter WL, Smithers BM, Rusch VW, Wijnhoven BPL, Chen KL, Davies AR, D’Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Cecconello I, Allum WH, Cerfolio RJ, Pera M, Griffin SM, Buger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Lerut TEMR, Orringer MB, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH. Worldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus. 2016;29:724–33.Google Scholar
  23. 23.
    Rice TW, Lerut TEMR, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, van Lanschot J, Chen KN, Davies AR, D’Journo XB, Kesler KA, Luketich JD, Ferguson MK, Rasanen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathological staging data. Dis Esophagus. 2016;29:715–23.Google Scholar
  24. 24.
    Japan Esophageal Society. Japanese classification of esophageal cancer. 10th ed. Tokyo: Kanehara; 2007. (in Japanese)Google Scholar
  25. 25.
    Japan Esophageal Society. Japanese classification of esophageal cancer. 10th ed. Tokyo: Kanehara; 2008.Google Scholar
  26. 26.
    Japan Esophageal Society. Japanese classification of esophageal cancer. 11th ed. Tokyo: Kanehara; 2015. (in Japanese)Google Scholar
  27. 27.
    Japan Esophageal Society. Japanese classification of esophageal cancer. 11th edition: part I. Esophagus. 2017a;14:1–36.CrossRefGoogle Scholar
  28. 28.
    Japan Esophageal Society. Japanese classification of esophageal cancer. 11th edition: part II and III. Esophagus. 2017b;14:37–65.CrossRefGoogle Scholar
  29. 29.
    Japanese Society of Esophageal Diseases. Esophageal cancer–descriptive rules in clinic and pathology. 2nd ed. Tokyo/Kyoto: Kanehara; 1972. (in Japanese)Google Scholar
  30. 30.
    Japanese Society of Esophageal Diseases. Carcinoma of the esophagus–descriptive rules in clinic and pathology. 3rd ed. Tokyo/Kyoto: Kanehara; 1973. (in Japanese)Google Scholar
  31. 31.
    Japanese Society of Esophageal Diseases. Carcinoma of the esophagus–descriptive rules in clinic and pathology. 4th ed. Tokyo/Kyoto: Kanehara; 1974. (in Japanese)Google Scholar
  32. 32.
    Japanese Society of Esophageal Diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 5th ed. Tokyo/Osaka/Kyoto: Kanehara; 1976. (in Japanese)Google Scholar
  33. 33.
    Japanese Society of Esophageal Diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 6th ed. Tokyo/Osaka/Kyoto: Kanehara; 1984. (in Japanese)Google Scholar
  34. 34.
    Japanese Society of Esophageal Diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 7th ed. Tokyo: Kanehara; 1989. (in Japanese)Google Scholar
  35. 35.
    Japanese Society of Esophageal Diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 8th ed. Tokyo: Kanehara; 1992. (in Japanese)Google Scholar
  36. 36.
    Japanese Society of Esophageal Diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 9th ed. Tokyo: Kanehara; 1999. (in Japanese)Google Scholar
  37. 37.
    Japanese Society of Esophageal Diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 9th ed. Tokyo: Kanehara; 2001.Google Scholar
  38. 38.
    Nabeya K, Akiyama H, Nakayama R, Ogawa Y, Soga J. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg. 1976;6:69–86.CrossRefGoogle Scholar
  39. 39.
    Fujita H. History of the Japanese classification of esophageal cancer. Esophagus. 2011;8:233–45.CrossRefGoogle Scholar
  40. 40.
    Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the esophagogastric junction–classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82.CrossRefGoogle Scholar
  41. 41.
    Nishi M, Kajisa T, Akune T, Kimitsuki K, Nagata M, Kawa S, Nishiseto N, Suenaga T, Kihara K, Tomari N. Cardia cancer–proposal of cancer in the esophagogstric junction. Geka Shinryo (Surgical Diagnosis and Treatment). 1973;15:1328–38. (in Japanese)Google Scholar
  42. 42.
    Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study. 12th ed. Tokyo: Kanehara; 1993. (in Japanese)Google Scholar
  43. 43.
    Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 1st ed. Tokyo: Kanehara; 1995.Google Scholar
  44. 44.
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 14th ed. Tokyo: Kanehara; 2010. (in Japanese)Google Scholar
  45. 45.
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 15th ed. Tokyo: Kanehara; 2017. (in Japanese)Google Scholar
  46. 46.
    Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H, Fujishiro M, Oyama T, Uno T, The Registration Committee for Esophafgeal Cancer of the Japan Esophageal Society. Efficacy of lymph node dissection for each station based on esophageal cancer location. Esophagus. 2016;13:138–45.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of SurgeryShintakeo HospitalSagaJapan

Personalised recommendations